Sars
Health care workers from 2003 SARS outbreak more resilient during COVID-19
Evidence mounts supporting inhaled nitric oxide as COVID-19 treatment
Abiomed acquires ECMO developer
Study investigates estrogen patch use to lessen COVID-19 complications
As researchers continue to assess complications of COVID-19, one striking difference has become clear — men who contract the novel coronavirus are more likely to be intubated or die compared with women. Animal model studies of the SARS virus suggest that the age and sex differences in COVID-19 symptom severity may be due to the protective and acute actions of estrogen, and researchers are initiating a trial designed to find out whether a transdermal estrogen patch placed on the skin of COVID-19-positive patients can reduce symptom severity compared with regular care.
Teaching ‘old drugs new tricks’: Experts rush to identify therapeutics for COVID-19
Cardiology societies recommend patients taking ACE inhibitors, ARBs who contract COVID-19 should continue treatment
Several American and European cardiology societies issued statements to dispel misinformation circulating about an association between treatment with renin-angiotensin-aldosterone system antagonists such as ACE inhibitors and angiotensin receptor blockers and increased risk for COVID-19 and increased severity of the disease for those who have contracted COVID-19.
‘There’s no need to panic’: What PCPs need to know about COVID-19
Q&A: Managing pediatric anxiety in an outbreak environment
Last week, WHO officially declared the novel coronavirus outbreak a Public Health Emergency of International Concern. Although few cases have been reported thus far in the United States, the virus’ impact may be reaching beyond the physical scope and affecting the mental health of children and adolescents by stoking anxiety, according to Robin Gurwitch, PhD, psychologist at Duke University Medical Center.